Log In
BCIQ
Print this Print this
 

ACU-D1

  Manage Alerts
Collapse Summary General Information
Company Accuitis Inc.
Description26S proteasome inhibitor of nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor beta (NFKBIB; IKBB)
Molecular Target Nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor beta (NFKBIB) (IKBB)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationRosacea
Indication DetailsTreat Rosacea
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today